Egypt Parkinson Disease Market Report 2022 to 2030

Egypt Parkinson Disease Market Analysis

$ 3999

Egypt parkinson disease market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key business drivers are anticipated to include the high prevalence of Parkinson's disease (PD) in western countries, the aging global population, which is at a high risk of contracting the disease, and the strong pipeline of drugs that treat the condition. Some of the major key players in this market are Sunovion Pharmaceuticals, Adamas Pharmaceuticals, Neurocrine Biosciences, Supernus Pharmaceuticals, etc.

ID: IN10EGPH358 CATEGORY: Pharmaceuticals GEOGRAPHY: Egypt AUTHOR: Riddhi Solanki

Buy Now

Egypt Parkinson Disease Market Analysis Summary

Egypt Parkinson Disease Market is valued at around $8.7 Mn in 2022 and is projected to reach $20.8 Mn by 2030, exhibiting a CAGR of 11.53% during the forecast period 2023-2030.

A brain ailment called parkinson's disease causes the loss of nerve cells in a specific area of the brain. It has a variety of effects on a person, including stiffness, depression, memory problems, challenges with balance and coordination, blood pressure, and thinking. Although there is no known cure for the condition, there are several treatment options, including surgery, medicines, and other therapies. Levodopa is a key component of Parkinson's treatment. To counteract carbidopa's numerous side effects, such as nausea, vomiting, low blood pressure, and restlessness, levodopa is routinely used with it. Due to changing environmental factors and genetic predisposition, the size of the Parkinson's disease treatment market is growing. Key business drivers are anticipated to include the high prevalence of Parkinson's Disease (PD) in western countries, the aging global population, which is at a high risk of contracting the disease, and the strong pipeline of drugs that treat the condition. The major key players in this market are Sunovion Pharmaceuticals, Adamas Pharmaceuticals, Neurocrine Biosciences, Supernus Pharmaceuticals, Kyowa Kirin, AbbVie, Integrative Research Laboratories AB, Rusan Pharma, Annovis Bio Inc., Cerevel Therapeutics, AMneal Pharmaceuticals

Market Dynamics

Market Growth Drivers

Strategic research alliances are being paved by the studies being conducted by numerous pharmaceutical companies to develop potential treatments for Parkinson's disease. The market revenue will profit from this element in turn. For instance, in October 2018, Pfizer Inc., a well-known pharmaceutical company, teamed up with Bain Capital to launch Cerevel Therapeutics, a biopharmaceutical company that will develop medications for Parkinson's disease and other conditions of the central nervous system. This move will help the Parkinson's disease market grow.

Market Restraints

Parkinson's disease currently has no known cure, only symptomatic relief from therapy. The market is severely constrained by the absence of disease-modifying treatments because patients and healthcare professionals are still looking for more potent therapeutic options. Strict rules and approval procedures apply to the pharmaceutical and healthcare industries. Before authorizing novel therapies, regulatory organizations like the U.S. Food and Drug Administration (FDA) demand thorough clinical trials and safety information. These legal requirements may cause market entry delays and raise development expenses.

Competitive Landscape

Key Players

Sunovion Pharmaceuticals
Adamas Pharmaceuticals
Neurocrine Biosciences
Supernus Pharmaceuticals
Kyowa Kirin
AbbVie
Integrative Research Laboratories AB
Rusan Pharma
Annovis Bio Inc.
Cerevel Therapeutics
AMneal Pharmaceuticals

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Egypt Parkinson Disease Market Segmentation

By Drug Class

Decarboxylase Inhibitors
Dopamine Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitors
Others

By Route of Administration

Oral
Parenteral
Transdermal

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.